National Institute for Occupational Safety and Health; Assessment of Respiratory Exposure Hazards in Composting
Federal RegisterJun 11, 1997
Ask Donna
What actually matters in this document.
Text
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[Announcement 738]
National Institute for Occupational Safety and Health; Assessment
of Respiratory Exposure Hazards in Composting
Introduction
The Centers for Disease Control and Prevention (CDC) announces the
availability of fiscal year (FY) 1997
[[Page 31826]]
funds for a cooperative agreement to conduct cross-sectional studies at
composting facilities of respiratory exposures and respiratory health
effects among compost workers.
CDC is committed to achieving the health promotion and disease
prevention objectives of Healthy People 2000, a national activity to
reduce morbidity and mortality and improve the quality of life. This
announcement is related to the priority area of Occupational Safety and
Health. (For ordering a copy of Healthy People 2000, see the section
Where to Obtain Additional Information.)
CDC, National Institute for Occupational Safety and Health (NIOSH)
is committed to the program priorities developed by the National
Occupational Research Agenda (NORA). (For ordering a copy of the NORA,
see the section WHERE TO OBTAIN ADDITIONAL INFORMATION.)
Authority
This program is authorized under Sections 20(a) and 22(e)(7) of the
Occupational Safety and Health Act of 1970 (29 U.S.C. 669(a) and
671(e)(7)).
Smoke-Free Workplace
CDC strongly encourages all grant recipients to provide a smoke-
free workplace and to promote the nonuse of all tobacco products, and
Public Law 103-227, the Pro-Children Act of 1994, prohibits smoking in
certain facilities that receive Federal funds in which education,
library, day care, health care, and early childhood development
services are provided to children.
Eligible Applicants
Applications may be submitted by public and private, non-profit and
for-profit organizations and governments, and their agencies. Thus,
universities, colleges, research institutions, hospitals, other public
and private organizations, State and local health departments or their
bona fide agents, federally recognized Indian tribal governments,
Indian tribes or Indian tribal organizations, and small, minority- and/
or women-owned businesses are eligible to apply.
Note: Public Law 104-65, dated December 19, 1995, prohibits an
organization described in section 501(c)(4) of the IRS Code of 1986,
that engages in lobbying activities to influence the Federal
Government, from receiving Federal funds.
Availability of Funds
Approximately $200,000 will be available in FY 1997 to fund up to
two awards at approximately $100,000 each. It is expected that the
awards will begin on or about September 30, 1997, and will be made for
12-month budget periods within the project period of up to 3 years. The
funding estimate is subject to change.
Continuation awards within the project period will be made on the
basis of satisfactory progress and the availability of funds.
Use of Funds
Restrictions on Lobbying
Applicants should be aware of restrictions on the use of HHS funds
for lobbying of Federal or State legislative bodies. Under the
provisions of 31 U.S.C. Section 1352 (which has been in effect since
December 23, 1989), recipients (and their subtier contractors) are
prohibited from using appropriated Federal funds (other than profits
from a Federal contract) for lobbying Congress or any Federal agency in
connection with the award of a particular contract, grant, cooperative
agreement, or loan. This includes grants/cooperative agreements that,
in whole or in part, involve conferences for which Federal funds cannot
be used directly or indirectly to encourage participants to lobby or to
instruct participants on how to lobby.
In addition, the FY 1997 HHS Appropriations Act, which became
effective October 1, 1996, expressly prohibits the use of 1997
appropriated funds for indirect or ``grass roots'' lobbying efforts
that are designed to support or defeat legislation pending before State
legislatures. This new law, Section 503 of Pub. L. No. 104-208,
provides as follows:
Sec. 503(a) No part of any appropriation contained in this Act
shall be used, other than for normal and recognized executive-
legislative relationships, for publicity or propaganda purposes, for
the preparation, distribution, or use of any kit, pamphlet, booklet,
publication, radio, television, or video presentation designed to
support or defeat legislation pending before the Congress, * * * except
in presentation to the Congress or any State legislative body itself.
(b) No part of any appropriation contained in this Act shall be
used to pay the salary or expenses of any grant or contract recipient,
or agent acting for such recipient, related to any activity designed to
influence legislation or appropriations pending before the Congress or
any State legislature.
Department of Labor, Health and Human Services, and Education, and
Related Agencies Appropriations Act, 1997, as enacted by the Omnibus
Consolidated Appropriations Act, 1997, Division A, Title I, Section
101(e), Pub. L. No. 104-208 (September 30, 1996).
Background
Composting is the decomposition of organic materials under aerobic
conditions which produces a stable, humus-like material which can be
used as a soil amendment. Materials composted can include yard waste,
food/household waste, food processing waste, agricultural wastes,
biosolids, and animal wastes. The recycling of biosolids and the
organic fractions of municipal solid waste is increasing because of the
benefits that can arise and because the disposal alternatives such as
land filling and incineration are more costly, unpopular, or restricted
by law. The consequence of this is a dramatic increase in the number of
composting operations and the number of workers exposed to organic
dusts at these facilities. The proceedings from a national composting
council workshop indicate that there were approximately 2500 composting
facilities operating in the United States during 1992 with a large
expected growth rate (over 45 percent) in the number of composting
facilities during subsequent years. The rapid growth in this industry,
combined with the potential for worker exposure to organic dusts
containing many toxic and immunogenic constituents, indicates the need
for studies to address potential respiratory health problems among
workers in this industry. Upper respiratory tract irritation, organic
dust toxic syndrome (ODTS), asthma, bronchitis, and hypersensitivity
pneumonitis are among the respiratory health problems described to
occur from organic dust exposures such as those associated with
composting.
Composting is an emerging technology area. Under the NIOSH National
Occupational Research Agenda (NORA), emerging technologies represent a
priority area for research efforts to (1) Assess their potential to
cause harm to workers, (2) evaluate specific worksites, (3) develop
effective control strategies where occupational hazards exist, (4)
identify superior new technologies that diminish risk, and (5) share
information for the benefit of all persons at risk and those
responsible for managing the risk.
This project addresses many of these emerging technology criteria
described in NORA.
Purpose
The purpose of this project is to conduct research to identify
potential exposure hazards and respiratory health problems among
workers in the composting industry. This information
[[Page 31827]]
will be used to promote respiratory health for this workforce and
direct prevention efforts as appropriate.
The specific objectives for this cooperative agreement program
include the following: develop a research protocol(s) for a cross-
sectional study of respiratory exposures and respiratory health effects
among workers employed at composting facilities; conduct in-depth
environmental investigations of respiratory exposure hazards at
selected composting facilities; conduct in-depth clinical
investigations on the respiratory health status of workers at selected
composting facilities; and describe the composting processes used at
each survey site including the control procedures used to reduce worker
exposures.
Note: Protocols should exclude sampling sites in Department of
Health and Human Services (DHHS) Region VII from the sample (DHHS
Region VII includes the following States: Iowa, Kansas, Missouri,
and Nebraska). This exclusion is to avoid duplication with ongoing
composting research efforts completed through the NIOSH funded
Centers for Agriculture Research, Education and Disease Injury and
Prevention in DHHS Region VII.
Program Requirements
In conducting activities to achieve the purpose of this agreement,
the recipient will be responsible for conducting activities under A.
(Recipient Activities) below, and CDC/NIOSH will be responsible for
conducting activities under B. (CDC/NIOSH Activities) below:
A. Recipient Activities
1. Develop a research protocol(s) for a cross-sectional study of
respiratory exposures and respiratory effects among workers employed at
composting facilities. Obtain scientific peer review of the
protocol(s), revise, and finalize the protocol(s).
2. Conduct a comprehensive environmental investigation of
respiratory exposure hazards at selected composting facilities.
Personal and area environmental sampling data collected from each of
these facilities should include, at a minimum, particulate not
otherwise regulated (formerly known as ``total dust''), metals,
endotoxins, viable microorganisms, and ammonia.
3. Conduct in-depth clinical investigations on the respiratory
health status of workers at selected composting facilities. Study
design should take into account sources of bias in particular the
problems encountered when limiting the study to current employees.
Clinical investigations should include, at a minimum:
a. The development and administration of a questionnaire designed
to gather information on work and exposure history and respiratory
health effects. The questionnaire should be administered to all members
of this study population.
b. The development and implementation of a pulmonary function
testing program appropriate to the investigation of respiratory health
effects among compost workers at selected facilities.
4. Clarify the composting processes used at each survey site
including the control procedures used to reduce worker exposures.
5. Collaborate with CDC/NIOSH scientists on study research efforts.
6. Report and disseminate, if desired, research results and
relevant health and safety education and training information to
appropriate health care providers, the scientific community,
agricultural workers and their families, management and union or other
worker representatives, and Federal, State, and local agencies.
Emphasis should be placed on the rapid dissemination of significant
public health findings and the translation of research findings into
prevention efforts.
B. CDC/NIOSH Activities
1. Provide technical assistance in the areas of program development
and study research efforts, implementation, maintenance.
2. Provide technical assistance, if needed, related to the
development and implementation of the pulmonary function testing
program.
3. Provide technical assistance, if needed, related to the
collection, review and/or analysis of data.
4. Collaborate in the reporting and dissemination of research
results and relevant health and safety education and training
information.
Technical Reporting Requirements
An original and two copies of semi-annual progress reports are
required. Timelines for the semi-annual reports will be established at
the time of award. Final financial status and performance reports are
required no later than 90 days after the end of the project period. All
reports are submitted to the Grants Management Branch, Procurement and
Grants Office, CDC.
Semi-annual progress report should include:
A. A brief program description.
B. A listing of program goals and objectives accompanied by a
comparison of the actual accomplishments related to the goals and
objectives established for the period.
C. If established goals and objectives to be accomplished were
delayed, describe both the reason for the deviation and anticipated
corrective action or deletion of the activity from the project.
Application Content
The entire application, including appendices, should not exceed 40
pages and the Proposal Narrative section contained therein should not
exceed 25 pages. Pages should be clearly numbered and a complete index
to the application and any appendices included. The original and each
copy of the application must be submitted unstapled and unbound. All
materials must be typewritten, double-spaced, with unreduced type (font
size 12 point) on 8\1/2\'' by 11'' paper, with at least 1'' margins,
headers, and footers, and printed on one side only. Do not include any
spiral or bound materials or pamphlets.
The applicant should provide a detailed budget, with accompanying
justification of all operating expenses, that is consistent with the
stated objectives and planned activities of the project. CDC may not
approve or fund all proposed activities. Applicants should be precise
about the program purpose of each budget item. For contracts described
within the application budget, applicants should name the contractor,
if known; described the services to be performed and provide an
itemized breakdown and justification for the estimated cost of the
contract; the kinds of organizations or parties to be selected; the
period of performance; and the method of selection. Place budget
narrative pages showing, in detail, how funds in each object class will
be spent, directly behind form 424A. Do not put these pages in the body
of the application.
The applicant should provide a detailed description of first-year
activities and briefly describe future-years objectives and activities.
A. Title Page
The heading should include the title of grant program, project
title, organization, name and address, project director's name address
and telephone number.
B. Abstract
A one page, singled-spaced, typed abstract must be submitted with
the application. The heading should include the title of grant program,
project title, organization, name and address, project director and
telephone number. This abstract should include a work plan identifying
activities to be developed, specific activities to be
[[Page 31828]]
completed, and a time-line for completion these activities.
C. Proposal Narrative
The narrative of each application must:
1. Briefly state the applicant's understanding of the need or
problem to be addressed and the purpose of this cooperative agreement.
This should include a draft protocol for the study. The protocol(s)
should include:
(a) A sampling strategy to insure that a representative sample of
composting operations and technologies are included in the study, and
(b) The sampling strategy should maximize the number of study sites
and include a representative sample based on geographic considerations.
2. (a) Describe clearly the objectives of this project, the steps
to be taken in planning and implementing this project, and the
respective responsibilities of the applicant for carrying out those
steps.
(b) Provide a proposed schedule for accomplishing each of the
activities to be carried out in this project and a method of evaluating
the accomplishments.
3. Provide documentation of access to potential study sites with
the sample characteristics specified, and provide documentation of
management and labor representatives to participate in the intervention
study.
4. Document the applicant's expertise in the area of exposure and
health assessment as they pertain to occupational safety and health.
5. Provide the name, qualifications, and proposed time allocation
of the Project Director who will be responsible for administering the
project. Describe staff, experience, facilities, equipment available
for performance of this project, and other resources that define the
applicant's capacity or potential to accomplish the requirements stated
above. List the names (if known), qualifications, and time allocations
of the existing professional staff to be assigned to (or recruited for)
this project, the support staff available for performance of this
project, and the available facilities including space.
6. Human Subjects: State whether or not Humans are subjects in this
proposal. (See Human Subjects in the Evaluation Criteria and Other
Requirements sections.)
7. Inclusion of women, ethnic, and racial groups:
Describe how the CDC policy requirements will be met regarding the
inclusion of women, ethnic, and racial groups in the proposed research.
(See Women, Racial and Ethnic Minorities in the Evaluation Criteria and
Other Requirements sections.)
8. Provide a detailed budget which indicates: (a) anticipated costs
for personnel, travel, communications, postage, equipment, supplies,
etc., and (b) all sources of funds to meet those needs.
Evaluation Criteria
Applications will be reviewed and evaluated according to the
following criteria:
A. Background and Need (20%)
Responsiveness to the purpose of this project, including the
applicant's understanding of the objectives of the proposed cooperative
agreement and the relevance of the proposal to the objectives.
B. Goals, Objectives and Methods (25%)
1. The extent to which the proposed goals and objectives are
clearly stated, time-phased, and measurable. The extent to which the
methods are sufficiently detailed to allow assessment of whether the
objectives can be achieved for the budget period. The extent to which a
qualified plan is proposed that will help achieve the goals stated in
the proposal.
2. The degree to which the applicant has met the CDC policy
requirements regarding the inclusion of women, ethnic, and racial
groups in the proposed project. This includes: (a) The proposed plan
for the inclusion of both sexes and racial and ethnic minority
populations for appropriate representation; (b) The proposed
justification when representation is limited or absent; (c) A statement
as to whether the design of the study is adequate to measure
differences when warranted; and (d) A statement as to whether the plan
for recruitment and outreach for study participants include the process
of establishing partnerships with community(ies) and recognition of
mutual benefits.
C. Strength of Programs (20%)
Strength of the applicant's environmental and clinical research
programs including a demonstrated ability in the conduct of
occupational health studies involving organic dusts, gases, and
respiratory health assessment.
D. Project Management and Staffing Plan (20%)
Training and experience, qualifications, and time commitment of the
project director, staff, and organization. This includes a Project
director who is a distinguished scientist and technical expert and
staff with the necessary training and experience sufficient to
accomplish proposed project.
E. Experience/Expertise (10%)
Applicant's knowledge/understanding and experience in the
composting industry.
F. Facilities and Resources (5%)
Efficiency of resources and novelty of program. This includes the
efficient use of existing and proposed personnel with assurances of a
major time commitment of the Project Director to the program and the
novelty of program approach.
G. Human Subjects (Not Scored)
Whether or not exempt from the DHHS regulations, are procedures
adequate for protection of human subjects? Recommendations on the
adequacy of protections include: (1) Protections appear adequate, and
there are no comments to make or concerns to raise, (2) protections
appear adequate, but there are comments regarding the protocol, (3)
protections appear inadequate and the Objective Review Group has
concerns related to human subjects, or (4) disapproval of the
application is recommended because the research risks are sufficiently
serious and protection against the risks are inadequate as to make the
entire application unacceptable.
H. Budget Justification (Not Scored)
The budget will be evaluated to the extent that it is reasonable,
clearly justified, and consistent with the intended use of funds.
Executive Order 12372 Review
Applications are subject to Intergovernmental Review of Federal
Programs as governed by Executive Order (E.O.) 12372. E.O. 12372 sets
up a system for State and local government review of proposed Federal
assistance applications. Applicants (other than federally recognized
Indian tribal governments) should contact their State Single Point of
Contact (SPOC) as early as possible to alert them to the prospective
applications and receive any necessary instructions on the State
process. For proposed projects serving more than one State, the
applicant is advised to contact the SPOC for each affected State. A
current list of SPOCs is included in the application kit.
If SPOCs have any State process recommendations on applications
submitted to CDC, they should be sent to Victoria Sepe, Grants
Management Specialist, Grants Management Branch, Procurement and Grants
Office, Centers
[[Page 31829]]
for Disease Control and Prevention (CDC), 255 East Paces Ferry Road,
NE., Room 321, Atlanta, GA 30305, no later than September 1, 1997. The
Program Announcement Number 738 and Program Title should be referenced
on the document. The granting agency does not guarantee to
``accommodate or explain'' State process recommendations it receives
after that date.
Indian tribes are strongly encouraged to request tribal government
review of the proposed application. If tribal governments have any
tribal process recommendations on applications submitted to CDC, they
should forward them to: Victoria Sepe, Grants Management Specialist,
Grants Management Branch, Centers for Disease Control and Prevention,
255 East Paces Ferry Road, NE., Room 321, Mailstop E-13, Atlanta, GA
30305. This should be done no later than September 1, 1997. The
granting agency does not guarantee to ``accommodate or explain'' for
tribal process recommendations it receives after that date.
Public Health System Reporting Requirements
This program is not subject to the Public Health System Reporting
Requirements.
Catalog of Federal Domestic Assistance Number
The Catalog of Federal Domestic Assistance Number for this program
is 93.262.
Other Requirements
Paperwork Reduction Act
Projects funded through the cooperative agreement mechanism of this
program involving the collection of information from 10 or more
individuals will be subject to review and approval by the Office of
Management and Budget (OMB) under the Paperwork Reduction Act.
Human Subjects
If the proposed project involves research on human subjects, the
applicant must comply with the DHHS Regulations, 45 CFR Part 46,
regarding the protection of human subjects. Assurance must be provided
to demonstrate the project will be subject to initial and continuing
review by an appropriate institutional review committee. The applicant
will be responsible for providing assurance in accordance with the
appropriate guidelines and form provided in the application kit.
In addition to other applicable committees, Indian Health Service
(IHS) institutional review committees also must review the project if
any component of IHS will be involved or will support the research. If
any American Indian community is involved, its tribal government must
also approve that portion of the project applicable to it.
Women and Minority Inclusion Policy
It is the policy of the Centers of Disease Control and Prevention
(CDC) to ensure that women and racial and ethnic groups will be
included in CDC supported research projects involving human subjects,
whenever feasible and appropriate. Racial and ethnic groups are those
defined in OMB Directive No. 15 and include American Indian, Alaskan
Native, Asian, Pacific Islander, Black and Hispanic. Applicants shall
ensure that women, racial and ethnic minority population are
appropriately represented for research involving human subjects. Where
clear and compelling rationale exist that inclusion is inappropriate or
not feasible, this situation must be explained as part of the
application. In conducting the review of applications for scientific
merit, review groups will evaluate proposed plans for inclusion of
minorities and both sexes as part of the scientific assessment and
assigned score. This policy does not apply to research studies when the
investigator cannot control the race, ethnicity and/or sex of subjects.
Further guidance on this policy is contained in the Federal Register,
Vol. 60, No. 179, Friday, September 15, 1995, pages 47947-47951.
Application Submission and Deadline
A. Preapplication Letter of Intent
Although not a prerequisite of application, a non-binding letter of
intent-to-apply is requested from potential applicants. The letter
should be submitted to Victoria Sepe, Grants Management Specialist,
Grants Management Branch, Procurement and Grants Office, CDC at the
address listed in this section. It should be postmarked no later than
July 1, 1997. The letter should identify Program Announcement 738 and
name of the principal investigator. The letter of intent does not
influence review or funding decisions, but it will enable CDC to plan
the review more efficiently and will ensure that each applicant
receives timely and relevant information prior to application
submission.
B. Application
The original and two copies of the application PHS Form 5161-1
(Revised 7/92, OMB Number 0937-0189) must be submitted to Victoria
Sepe, Grants Management Specialist, Grants Management Branch,
Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), 255 East Paces Ferry Road, NE., Room 321, Atlanta, GA
30305, on or before July 18, 1997.
1. Deadline: Applications will be considered as meeting the
deadline if they are either:
(a) Received on or before the deadline date, or
(b) Sent on or before the deadline date and received in time for
submission to the objective review group. (The applicants must request
a legibly dated U.S. Postal Service postmark or obtain a receipt from a
commercial carrier or the U.S. Postal Service. Private metered
postmarks will not be acceptable as proof of timely mailing.)
2. Late Applicants: Applications that do not meet the criteria in
1.(a) or 1.(b) above are considered late applications. Late
applications will not be considered and will be returned to the
applicants.
Where to Obtain Additional Information
To receive additional written information call (404) 332-4561. You
will be asked to leave your name, address, and telephone number and
will need to refer to NIOSH Announcement 738. You will receive a
complete program description, information on application procedures,
and application forms. CDC will not send application kits by facsimile
or express mail. Please refer to NIOSH Announcement Number 738 when
requesting information and submitting an application.
If you have questions after reviewing the contents of all the
documents, business management technical assistance may be obtained
from Victoria Sepe, Grants Management Specialist, Grants Management
Branch, Procurement and Grants Office, Centers for Disease Control and
Prevention (CDC), Mailstop E-13, Room 321, 255 East Paces Ferry Road,
NE., Atlanta, GA 30305, telephone (404) 842-6804, Internet:
[email protected].
Programmatic technical assistance may be obtained from Patrick
Hintz, M.S., Division of Respiratory Disease Studies, National
Institute for Occupational Safety and Health, Centers for Disease
Control and Prevention (CDC), Mailstop P04/111, 1095 Willowdale Road,
Morgantown, WV 26505-2888, telephone (304) 285-5744, Internet:
[email protected].
This and other CDC announcements are available through the CDC
homepage
[[Page 31830]]
on the Internet. The address for the CDC homepage is: http://
www.cdc.gov.
Potential applicants may obtain a copy of Healthy People 2000 (Full
Report, Stock No. 017-001-00474-0) or Healthy People 2000 (Summary
Report, Stock No. 017-001-00473-1) referenced in the Introduction
section through the Superintendent of Documents, Government Printing
Office, Washington, DC 20402-9325, telephone (202) 512-1800.
The National Occupational Research Agenda: copies of this
publication may be obtained from the National Institute for
Occupational Safety and Health, Publications Office, 4676 Columbia
Parkway, Cincinnati, OH 45226-1998 or telephone 1-800-356-4674, and is
available through the NIOSH Home Page; http://www.cdc.gov/niosh/
nora.html.
NORA Priority Research Areas
Disease and Injury
Allergic and Irritant Dermatitis
Asthma and Chronic Obstructive Pulmonary Disease
Fertility and Pregnancy Abnormalities
Hearing Loss
Infectious Diseases
Low Back Disorders
Musculoskeletal Disorders of the Upper Extremities
Traumatic Injuries
Work Environment and Workforce
Emerging Technologies
Indoor Environment
Mixed Exposures
Organization of Work
Special Populations at Risk
Research Tools and Approaches
Cancer Research Methods
Control Technology and Personal Protective Equipment
Exposure Assessment Methods
Health Services Research
Intervention Effectiveness Research
Risk Assessment Methods
Social and Economic Consequences of Workplace Illness and Injury
Surveillance Research Methods
Dated: June 4, 1997.
Diane D. Porter,
Acting Director, National Institute for Occupational Safety and Health,
Centers for Disease Control and Prevention (CDC).
[FR Doc. 97-15180 Filed 6-10-97; 8:45 am]
BILLING CODE 4163-19-P
This is a copy of a public record, reproduced as it was published. It is not legal advice, and it may not be the version a court would rely on. Check the official source before you cite it.